You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆匯港股聚焦(06.03)︱萬科企業5月實現合同銷售575.6億;信達生物PD-1獲批治療肺鱗癌
格隆匯 06-03 23:19

【業績預吿】

力勁科技(00558.HK)預計年度純利大幅增加至逾3.1億港元

【運營數據】

萬科企業(02202.HK)前5月合同銷售金額2868.1億元 同比增長16.07%

禹洲集團(01628.HK):前五月累計銷售416.94億元 同比增長35.63%

美的置業(03990.HK)首5月合同銷售691.3億元 同比增長89.40%

金地商置(00535.HK):1至5月合約銷售319.3億元 同比增長81.85%

合生創展集團(00754.HK):前5月合約銷售181.52億元 同比上升147.9%

信利國際(00732.HK):前五月綜合營業淨額91.58億港元 同比增加9%

德信中國(02019.HK):前五月累計合約銷售337.10億元 同比增長94.52%

首創置業(02868.HK):前5月累計簽約金額達305.9億元 同比增長55.7%

建業地產(00832.HK):5月取得物業合同銷售額75.67億元 同比增加29.2%

中原建業(09982.HK):前五月在管項目合約銷售109.77億元 同比增長47.5%

【股本重組】

美臻集團(01825.HK)擬"4合1"進行股份合併 更改每手買賣單位

【併購出售】

盈健醫療(01419.HK)附屬擬6380萬港元收購香港九龍常悦道物業

【投資運營】

信達生物(01801.HK):NMPA批准達伯舒®(信迪利單抗注射液)用於治療一線鱗狀非小細胞肺癌

遠大醫藥(00512.HK):集團獲得針對眼科術後抗炎鎮痛的改良型新藥在中國大陸及港澳地區的開發及商業化權利

虎視傳媒(01163.HK)設立全資附屬公司 加速佈局國內數字營銷業務

麗年國際(09918.HK)向一間美國定點照護分子診斷公司交付若干用於2019冠狀病毒快速測試測試儀對接儀器

【回購註銷】

海爾智家(06690.HK)6月3日回購170萬股A股及120.5萬股H股

爪哇控股(00251.HK)6月3日耗資4194.85萬港元回購500萬股

安德利果汁(02218.HK)6月3日耗資277.11萬港元回購39.7萬股

歡喜傳媒(01003.HK)6月3日耗資49.35萬港元回購26萬股

天鴿互動(01980.HK)6月3日耗資217萬港元回購152.6萬股

【股權激勵】

美高梅中國(02282.HK)授出1235.56萬份購股權

嘉和生物-B(06998.HK)授出609.61萬份購股權

藍月亮集團(06993.HK)採納股份獎勵計劃

禪遊科技(02660.HK)授出1600萬份購股權

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account